Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Loda

Showing results (311-320 of 409) with videos related to

Pageof 41
Sort By:
Nature Communications|June 8, 2021
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancerNicholas J Brady, Alyssa M Bagadion, Richa Singh, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 1, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptorsEddy J Chen, Adam G Sowalsky, Shuai Gao, et al.
Cancer Research|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Molecular Cancer Research : MCR|November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancerJia J Li, Alessandro Vasciaveo, Dimitrios Karagiannis, et al.
The American Journal of Pathology|May 22, 2010
Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasisElisa Benedettini, Lynette M Sholl, Michael Peyton, et al.
Prostate Cancer and Prostatic Diseases|March 13, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapySara Bleve, Francesco Ravera, Silvia Rodrigues, et al.
Cancer Cell|June 12, 2024
A Prostatic Intraepithelial Neoplasia-Dependent p27Kip1 Checkpoint Induces Senescence and Inhibits Cell Proliferation and Cancer ProgressionPradip K Majumder, Chiara Grisanzio, Fionnuala O'Connell, et al.
Pageof 41

Showing results (311-320 of 409) with videos related to

Sort By:
Pageof 41
Nature Communications|June 8, 2021
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancerNicholas J Brady, Alyssa M Bagadion, Richa Singh, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 1, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptorsEddy J Chen, Adam G Sowalsky, Shuai Gao, et al.
Cancer Research|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Molecular Cancer Research : MCR|November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancerJia J Li, Alessandro Vasciaveo, Dimitrios Karagiannis, et al.
The American Journal of Pathology|May 22, 2010
Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasisElisa Benedettini, Lynette M Sholl, Michael Peyton, et al.
Prostate Cancer and Prostatic Diseases|March 13, 2026
Lipidomic profiling in metastatic prostate cancer captures tumor metabolic rewiring and its modulation by androgen receptor-targeting therapySara Bleve, Francesco Ravera, Silvia Rodrigues, et al.
Cancer Cell|June 12, 2024
A Prostatic Intraepithelial Neoplasia-Dependent p27Kip1 Checkpoint Induces Senescence and Inhibits Cell Proliferation and Cancer ProgressionPradip K Majumder, Chiara Grisanzio, Fionnuala O'Connell, et al.
Pageof 41